Clinical Trials Browser

Unknown × Bile Duct Neoplasms × Irinotecan × Clear all

NCT03603834 2021-09-01

Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

Phase 2 Unknown

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma